Role of the α1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial.
about
Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals.Gene Expression Changes in Glutamate and GABA-A Receptors, Neuropeptides, Ion Channels, and Cholesterol Synthesis in the Periaqueductal Gray Following Binge-Like Alcohol Drinking by Adolescent Alcohol-Preferring (P) Rats.Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.Alcohol, stress, and glucocorticoids: From risk to dependence and relapse in alcohol use disorders.Influence of stress associated with chronic alcohol exposure on drinking.Probing for Neuroadaptations to Unpredictable Stressors in Addiction: Translational Methods and Emerging Evidence.Dysregulation of Brain Stress Systems Mediates Compulsive Alcohol Drinking.Effects of prazosin and doxazosin on yohimbine-induced reinstatement of alcohol seeking in rats.Effect of doxazosin on stress reactivity and the ability to resist smoking.Prazosin for Veterans with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: A Clinical Trial.Advances in Pharmacotherapy Development: Human Clinical Studies.Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin.Medications for alcohol use disorders: An overview.Noradrenergic targets for the treatment of alcohol use disorder.Enhanced Amygdala-Striatal Functional Connectivity during the Processing of Cocaine Cues in Male Cocaine Users with a History of Childhood Trauma.
P2860
Q36021630-D495D9D6-5C05-4B0C-B145-C092061C694AQ36834942-73064C07-8996-4E92-9B79-212F0F4290E0Q38718932-6AD11B89-8962-4E77-986B-CFFD40FB7590Q38980046-BA8860FB-AB12-4682-86E9-8431E052B922Q39255467-37A737FB-684E-4BB5-AF55-38C7FCEA5EA6Q39302789-E3649AF2-B0D8-4385-8C99-970D2CC82D23Q39365977-D9A1FFA8-7E20-4951-AA6E-787332FF6526Q39884301-3F0C91B0-1859-4292-B8E5-E0704DD63B8AQ40229079-88F3C2CA-558D-445B-9359-A48FCBA71367Q45327806-5D410282-4035-439F-81A6-BDBABD25A300Q47182010-263D5B3E-CE18-44D0-84D9-8D6CB078720BQ47851680-98DFCFEE-D2EB-40C1-B796-50AF5FF08478Q47942161-5EA10775-7BF3-4203-8645-695FD859D24CQ49825421-AD8056BA-AF77-423D-993E-E0190304FFF5Q52316998-85CD64AC-0FAE-4404-9C79-03BD4255DF52
P2860
Role of the α1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Role of the α1 blocker doxazos ...... t randomized controlled trial.
@ast
Role of the α1 blocker doxazos ...... t randomized controlled trial.
@en
type
label
Role of the α1 blocker doxazos ...... t randomized controlled trial.
@ast
Role of the α1 blocker doxazos ...... t randomized controlled trial.
@en
prefLabel
Role of the α1 blocker doxazos ...... t randomized controlled trial.
@ast
Role of the α1 blocker doxazos ...... t randomized controlled trial.
@en
P2093
P2860
P356
P1433
P1476
Role of the α1 blocker doxazos ...... t randomized controlled trial.
@en
P2093
Carolina L Haass-Koffler
George A Kenna
Lorenzo Leggio
Michael B Brickley
Robert M Swift
Steven M Edwards
William H Zywiak
P2860
P304
P356
10.1111/ADB.12275
P577
2015-06-02T00:00:00Z